These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9629752)

  • 1. [Effects of bromocriptine in patients with active rheumatoid arthritis].
    Figueroa F; Carrión F; Martínez ME; Rivero S; Mamani I; González G
    Rev Med Chil; 1998 Jan; 126(1):33-41. PubMed ID: 9629752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bromocriptine for refractory rheumatoid arthritis].
    Mader R
    Harefuah; 1997 Dec; 133(11):527-9, 591. PubMed ID: 9451892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine in rheumatic and autoimmune diseases.
    McMurray RW
    Semin Arthritis Rheum; 2001 Aug; 31(1):21-32. PubMed ID: 11503136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis.
    Nagafuchi H; Suzuki N; Kaneko A; Asai T; Sakane T
    J Rheumatol; 1999 Sep; 26(9):1890-900. PubMed ID: 10493666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
    Davis JC; Fessler BJ; Tassiulas IO; McInnes IB; Yarboro CH; Pillemer S; Wilder R; Fleisher TA; Klippel JH; Boumpas DT
    J Rheumatol; 1998 Sep; 25(9):1694-704. PubMed ID: 9733448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study.
    Baslund B; Tvede N; Danneskiold-Samsoe B; Larsson P; Panayi G; Petersen J; Petersen LJ; Beurskens FJ; Schuurman J; van de Winkel JG; Parren PW; Gracie JA; Jongbloed S; Liew FY; McInnes IB
    Arthritis Rheum; 2005 Sep; 52(9):2686-92. PubMed ID: 16142748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V; Tugwell P; Bombardier C; Maetzel A; Crawford B; Dorrier C; Thompson A; Wells G
    Arthritis Rheum; 1999 Sep; 42(9):1870-8. PubMed ID: 10513801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment.
    Shirinsky IV; Zheltova OI; Solovyova NY; Kozlov VA; Shirinsky VS
    Scand J Rheumatol; 2009; 38(1):23-7. PubMed ID: 18830905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand function tests are important and sensitive tools for assessment of treatment response in patients with rheumatoid arthritis.
    Eberhardt K; Sandqvist G; Geborek P
    Scand J Rheumatol; 2008; 37(2):109-12. PubMed ID: 18415767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
    Seitz M; Zwicker M; Wider B
    J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolactin, a link between the neuroendocrine and immune systems. Role in the pathogenesis of rheumatic diseases].
    Gutierez MA; Anaya JM; Cabrera GE; Vindrola O; Espinoza LR
    Rev Rhum Ed Fr; 1994 Apr; 61(4):278-85. PubMed ID: 7920527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin and growth hormone responses to hypoglycemia in patients with rheumatoid arthritis and ankylosing spondylitis.
    Rovensky J; Imrich R; Malis F; Zlnay M; Macho L; Koska J; Vigas M
    J Rheumatol; 2004 Dec; 31(12):2418-21. PubMed ID: 15570644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological modification of prolactinemia. Effects on cellular immune function in normal subjects].
    Figueroa F; Carrión F; González G; Rivero S; Arteaga E; Mamani I
    Rev Med Chil; 1993 Sep; 121(9):975-81. PubMed ID: 8191163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
    Higashida J; Wun T; Schmidt S; Naguwa SM; Tuscano JM
    J Rheumatol; 2005 Nov; 32(11):2109-15. PubMed ID: 16265687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
    Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
    Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.